Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
James M. Youakim, MD
Vice President, Clinical Development
Acadia Pharmaceuticals Inc
Poster(s):
072: Population Pharmacokinetic Modelling to Confirm Weight-Based Banded Dosing & Exposure-Response Efficacy Analyses to Support Trofinetide Treatment in Rett Syndrome
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
132: Limited Potential for Interactions Between Trofinetide, a New Treatment for Rett Syndrome, & Drugs Metabolized By CYP3A4
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
178: In Silico Physiologically Based Pharmacokinetic Model of the Effect of Hepatic Impairment on Trofinetide Exposures
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
